全球神经外科市场

预计到 2030 年全球神经外科市场规模将达 51 亿美元

全球神经外科市场规模预计在2024年为43亿美元，到2030年将达到51亿美元，在2024-2030年的分析期间内，复合年增长率为3.1%。神经介入器材是本报告分析的细分市场之一，预计其复合年增长率为4.0%，到分析期结束时规模将达到14亿美元。神经科学用内视镜细分市场在分析期间内的复合年增长率预计为3.7%。

美国市场预计将达到 12 亿美元，中国市场复合年增长率将达到 6.0%

美国神经外科市场规模预计在2024年达到12亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到10亿美元，在2024-2030年的分析期间内，复合年增长率为6.0%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为1.2%和2.4%。在欧洲，预计德国市场的复合年增长率为1.8%。

全球神经外科市场—主要趋势与驱动因素摘要

为什么神经外科正在发展成为全球外科实践的精准驱动领域？

神经外科是一门以外科手术治疗脑部、脊椎和周边神经疾病的医学专业，如今正因精准医疗、先进影像技术和微创技术而发生革命性的变化。神经外科曾专注于危及生命的急诊手术和高风险肿瘤切除术，如今涵盖了广泛的选择性和修復性手术，例如深部脑部刺激、脊髓减压手术、癫痫手术以及针对中风和动脉瘤的血管内治疗。

全球神经系统、创伤、脊椎和神经肿瘤病例的增加，推动了已开发经济体和新兴经济体对神经外科服务的需求。随着人口老化以及退化性脊髓疾病、中风和脑肿瘤负担的加重，神经外科正成为神经系统综合护理中不可或缺的一部分。此外，机器人技术、导航系统和术中监测的引入，使复杂的手术更加安全、可重复且创伤性更小，从而扩大了神经外科在修復和功能预后方面的作用。

机器人、影像和数据整合如何使神经外科手术更加准确和安全？

技术进步正在重新定义神经外科的手术格局。术中磁振造影 (MRI)、神经导航和机器人辅助系统使肿瘤切除、电极置入和脊椎内固定手术达到毫米级精度。这些技术使外科医生能够利用 3D 重建规划手术，模拟不同的手术路径，并根据即时解剖变化进行术中调整。影像导引手术(IGS) 越来越多地应用于微创开颅手术和内视镜经鼻颅底手术，以减少附带损伤并改善神经系统预后。

人工智慧 (AI) 和机器学习正应用于术前计划、术中决策支援和术后风险评估。基于 AI 的分割工具有助于识别关键脑区，而预测模型则有助于预测手术併发症和恢復时间。此外，电子健康记录、手术视讯分析和神经生理数据的整合正在增强多学科护理和长期结果追踪。这些技术创新不仅提高了手术的精准度，还透过远距学习和扩增实境培训平台，使神经外科专业知识更加普及。

哪些患者群体和医疗保健系统正在影响全球对神经外科服务的需求？

神经外科服务于广泛的患者群体，包括脑肿瘤、脑外伤、中风相关出血、水脑症、癫痫、椎间盘疾病以及 Chiari 畸形和脊柱裂等先天性异常患者。老年神经外科患者的比例正在增加，尤其是在退化性脊椎手术、脑血管手术和肿瘤切除术中。小儿神经外科仍是治疗先天性异常和神经发育障碍的重要专科。

北美凭藉其先进的医院基础设施、较高的手术量以及手术器械的持续创新，引领全球神经外科市场。欧洲紧随其后，原因是其拥有雄厚的公共医疗资金以及影像引导和机器人神经外科系统的广泛应用。亚太地区正在迅速扩张，尤其是在印度、中国、韩国和日本，这得益于患者人数的增加、神经外科培训计画的完善以及医疗覆盖率的提高。拉丁美洲、中东和非洲等新兴市场正透过医疗旅游、官民合作关係和外科手术计画等方式投资神经外科治疗。

什么将推动神经外科市场的长期成长和多学科整合？

神经外科市场的成长得益于全球神经系统和脊髓疾病负担的日益加重、外科技术的进步以及向微创和功能保留手术的转变。神经外科医生、神经科、放射科医生、麻醉师和復健专家之间日益密切的合作，使得提供全面的连续护理成为可能，从而改善患者的预后并加快康復速度。

未来的成长将由功能性神经外科（运动障碍、精神障碍、疼痛等）、脑机介面和植入式神经刺激设备的趋势决定。机器人自动化、云端基础的手术数据平台和远端神经外科将扩大手术范围并提高手术效率。随着神经外科继续向精准化、个人化和多学科发展，它将继续成为全球现代医疗保健中充满活力且不可或缺的支柱。

部分

产品类型（神经介入设备、神经科学用内视镜、神经外科手术用钻机、放射线手术系统、硬脑膜替代品、其他产品类型）、适应症（脑肿瘤适应症、脊椎和颅底肿瘤适应症、创伤性脑损伤适应症、颅颜创伤适应症、其他适应症）、最终用途（医院和专科诊所最终用途、门诊手术中心最终用途、其他最终用途）

受访公司范例（总合36家值得关注的公司）

• Abbott Laboratories
• Adeor Medical AG
• Aleva Neurotherapeutics
• B. Braun Melsungen AG
• Boston Scientific Corporation
• Brainlab AG
• Elekta AB
• Integra LifeSciences Holdings Corp.
• Johnson & Johnson（DePuy Synthes）
• Karl Storz SE & Co. KG
• LivaNova PLC
• Machida Endoscope Co., Ltd.
• Medtronic plc
• MicroVention Inc.（Terumo Group）
• NuVasive, Inc.
• Penumbra, Inc.
• Smith & Nephew plc
• Stryker Corporation
• Synaptive Medical Inc.
• Zimmer Biomet Holdings, Inc.

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口（成品和原始OEM）来预测其竞争地位的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括人为提高销货成本、盈利下降、供应链重组以及其他微观和宏观市场动态。

全球产业分析师密切关注来自全球顶尖首席经济学家（14,949位）、智库（62家）以及贸易和产业协会（171家）的专家的意见，以评估其对生态系统的影响并应对新的市场现实。我们追踪了来自每个主要国家的专家和经济学家对关税及其对本国影响的看法。

全球产业分析师预计，这场动盪将在未来2-3个月内逐渐平息，新的世界秩序将更加清晰地建立。全球产业分析师正在即时追踪这些事态发展。

2025年4月：谈判阶段

在4月的报告中，我们将探讨关税对全球整体市场的影响，并提供区域市场调整。我们的预测是基于历史数据和不断变化的市场影响因素。

2025年7月：最终关税调整

在各国宣布最终重置后，客户将在 7 月收到免费更新，最终更新将包含明确的关税影响分析。

相互和双边贸易及关税影响分析：

美国<>中国<>墨西哥<>加拿大<>欧盟<>日本<>印度<>其他176个国家

领先的产业经济学家：全球产业分析师知识库追踪了 14,949 位经济学家，其中包括来自民族国家、智库、贸易和产业协会、大型企业以及各领域专家的最具影响力的首席经济学家，他们共用了这场前所未有的全球经济状况模式转移的影响。我们超过 16,491 份报告大多遵循基于里程碑的两阶段发布计划。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Neurosurgery Market to Reach US$5.1 Billion by 2030

The global market for Neurosurgery estimated at US$4.3 Billion in the year 2024, is expected to reach US$5.1 Billion by 2030, growing at a CAGR of 3.1% over the analysis period 2024-2030. Neuro Interventional Devices, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Neuroendoscopes segment is estimated at 3.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 6.0% CAGR

The Neurosurgery market in the U.S. is estimated at US$1.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.0 Billion by the year 2030 trailing a CAGR of 6.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.2% and 2.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Global Neurosurgery Market - Key Trends & Drivers Summarized

Why Is Neurosurgery Evolving into a Precision-Centric Discipline Within Global Surgical Practice?

Neurosurgery, the medical specialty concerned with the surgical treatment of disorders affecting the brain, spine, and peripheral nerves, is undergoing a major transformation fueled by precision medicine, advanced imaging, and minimally invasive techniques. Once associated primarily with life-threatening emergencies or high-risk tumor resections, neurosurgery now encompasses a wide spectrum of elective and restorative procedures, including deep brain stimulation, spinal decompression, epilepsy surgery, and endovascular interventions for stroke and aneurysms.

The global rise in neurological diseases, traumatic injuries, spinal disorders, and neuro-oncological cases has increased the demand for neurosurgical services across both developed and developing economies. With populations aging and the burden of degenerative spinal disease, stroke, and brain tumors increasing, neurosurgery is becoming an essential part of integrated neurological care. Moreover, the incorporation of robotics, navigation systems, and intraoperative monitoring is making complex surgeries safer, more reproducible, and less invasive, expanding the role of neurosurgery in restorative and functional outcomes.

How Are Robotics, Imaging Technologies, and Data Integration Enhancing Neurosurgical Precision and Safety?

Technological advances are redefining the operational landscape of neurosurgery. Intraoperative MRI, neuronavigation, and robotic-assisted systems are enabling millimeter-level accuracy in tumor resections, electrode placement, and spinal instrumentation. These technologies allow surgeons to plan procedures with 3D reconstructions, simulate different surgical paths, and adapt intraoperatively based on real-time anatomical shifts. Image-guided surgery (IGS) is increasingly used in minimally invasive craniotomies and endoscopic transnasal skull base procedures, reducing collateral damage and improving neurological outcomes.

Artificial intelligence (AI) and machine learning are being applied to preoperative planning, intraoperative decision support, and postoperative risk assessment. AI-driven segmentation tools help identify critical brain regions, while predictive models assist in forecasting surgical complications or recovery timelines. Additionally, the integration of electronic health records, surgical video analysis, and neurophysiological data is enhancing multidisciplinary care and long-term outcome tracking. These innovations are not only elevating procedural accuracy but also democratizing neurosurgical expertise through remote learning and augmented reality training platforms.

Which Patient Segments and Healthcare Systems Are Shaping Global Demand for Neurosurgical Services?

Neurosurgery caters to a broad spectrum of patient populations, including individuals with brain tumors, traumatic brain injuries, stroke-related hemorrhages, hydrocephalus, epilepsy, spinal disc disease, and congenital malformations such as Chiari malformations or spina bifida. The elderly account for a growing proportion of neurosurgical patients, particularly for degenerative spine surgeries, cerebrovascular procedures, and tumor resections. Pediatric neurosurgery also remains a vital sub-specialty, addressing congenital anomalies and neurodevelopmental disorders.

North America leads the global neurosurgery market due to advanced hospital infrastructure, high surgical volumes, and continuous innovation in surgical devices. Europe follows closely, with strong public health funding and widespread adoption of image-guided and robotic neurosurgical systems. Asia-Pacific is rapidly expanding, particularly in India, China, South Korea, and Japan, driven by increasing patient volumes, improved neurosurgical training programs, and rising health insurance coverage. Emerging markets in Latin America, the Middle East, and Africa are investing in neurosurgical capacity through medical tourism, public-private partnerships, and surgical mission programs.

What Is Driving Long-Term Growth and Multidisciplinary Integration in the Neurosurgery Market?

The growth in the neurosurgery market is driven by the escalating global burden of neurological and spinal disorders, advancements in surgical technology, and the movement toward minimally invasive and function-preserving procedures. Increasing collaboration between neurosurgeons, neurologists, radiologists, anesthesiologists, and rehabilitation specialists is creating a holistic continuum of care that enhances patient outcomes and accelerates recovery.

Future growth will be shaped by trends in functional neurosurgery (e.g., for movement disorders, psychiatric conditions, and pain), brain-computer interfaces, and implantable neurostimulators. Robotic automation, cloud-based surgical data platforms, and tele-neurosurgery will enhance surgical reach and operational efficiency. As neurosurgery continues to evolve toward precision, personalization, and multidisciplinarity, it is poised to remain a dynamic and indispensable pillar of modern medical intervention worldwide.

SCOPE OF STUDY:

The report analyzes the Neurosurgery market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes, Other Product Types); Indication (Brain Cancer Indication, Spine & Skull Base Tumors Indication, Traumatic Brain Injuries Indication, Craniofacial Trauma Indication, Other Indications); End-Use (Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• Abbott Laboratories
• Adeor Medical AG
• Aleva Neurotherapeutics
• B. Braun Melsungen AG
• Boston Scientific Corporation
• Brainlab AG
• Elekta AB
• Integra LifeSciences Holdings Corp.
• Johnson & Johnson (DePuy Synthes)
• Karl Storz SE & Co. KG
• LivaNova PLC
• Machida Endoscope Co., Ltd.
• Medtronic plc
• MicroVention Inc. (Terumo Group)
• NuVasive, Inc.
• Penumbra, Inc.
• Smith & Nephew plc
• Stryker Corporation
• Synaptive Medical Inc.
• Zimmer Biomet Holdings, Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Neurosurgery - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Burden of Neurological Disorders Spurs Growth in Neurosurgical Procedures
  • Advances in Intraoperative Navigation Systems Strengthen Precision and Surgical Confidence
  • Increased Adoption of Robot-Assisted Neurosurgery Drives Efficiency and Patient Outcomes
  • Expansion of Neuroendoscopic Techniques Propels Minimally Invasive Surgical Interventions
  • Growing Utilization of 3D Imaging and AR/VR Platforms Enhances Pre-Surgical Planning Accuracy
  • Rise in Traumatic Brain Injuries and Spinal Disorders Expands Addressable Patient Pool
  • Integration of AI in Neurosurgical Workflows Throws the Spotlight on Predictive Analytics
  • Global Expansion of Neurosurgery Centers in Emerging Economies Drives Market Penetration
  • Improved Training Through Simulators and Virtual Labs Enhances Surgeon Proficiency and Case Volume
  • Development of Cost-Effective Neurosurgical Tools Supports Accessibility in Resource-Constrained Settings
  • Regulatory Approvals of Navigation-Assisted Implants Accelerate Technology Adoption
  • Growth in Awake Craniotomy Procedures Enhances Functional Outcomes and Recovery Metrics
  • Increased Clinical Focus on Pediatric Neurosurgery Supports Early Intervention Protocols
  • Postoperative Recovery Technologies Propel Demand for Comprehensive Surgical Ecosystems
  • Surge in Brain Tumor and Epilepsy Resections Drives Procedure-Specific Tool Demand
  • Rising Investment in Neurovascular Surgery Supports Treatment of Aneurysms and AVMs
  • Expansion of Hospital Neuroscience Programs Enhances Institutional Capacity and Case Load
  • Heightened Awareness of Neurosurgical Advancements Spurs Patient Willingness for Early Treatment
  • Variability in Neurosurgical Reimbursement Structures Creates Regional Access Inequities
  • Advancements in Neuro-monitoring Tools Support Real-Time Intraoperative Decision-Making
  • Global Initiatives for Stroke and Neurotrauma Management Reinforce Surgical Infrastructure Development
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Neurosurgery Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Neurosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Neurosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Neurosurgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Neuro Interventional Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Neuro Interventional Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Neuro Interventional Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Neuroendoscopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Neuroendoscopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Neuroendoscopes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Neurosurgical Drills by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Neurosurgical Drills by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Neurosurgical Drills by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Radiosurgery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Radiosurgery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Radiosurgery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Dura Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Dura Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Dura Substitutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Craniofacial Trauma Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Craniofacial Trauma Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Craniofacial Trauma Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Brain Cancer Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Brain Cancer Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Brain Cancer Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Spine & Skull Base Tumors Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Spine & Skull Base Tumors Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Spine & Skull Base Tumors Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Traumatic Brain Injuries Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Traumatic Brain Injuries Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Traumatic Brain Injuries Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Hospitals & Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Hospitals & Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Hospitals & Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 47: USA Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• JAPAN
  • Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• CHINA
  • Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 74: China Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• EUROPE
  • Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Neurosurgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Neurosurgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Neurosurgery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• FRANCE
  • Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 95: France Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 101: France Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• GERMANY
  • Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Germany 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 110: Germany Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Germany Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Germany 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Italy 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 119: Italy Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Italy Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Italy 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 122: UK Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: UK 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 128: UK Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: UK Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: UK 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Spain 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 137: Spain Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Spain Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Spain 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Russia 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 146: Russia Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Russia Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Russia 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Rest of Europe Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Rest of Europe 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Neurosurgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Neurosurgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Neurosurgery by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Asia-Pacific Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Asia-Pacific 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Australia 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 176: Australia Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Australia Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Australia 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• INDIA
  • Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 179: India Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: India 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 185: India Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: India Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: India 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: South Korea 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 194: South Korea Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: South Korea Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: South Korea 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Asia-Pacific Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Rest of Asia-Pacific 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Neurosurgery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Neurosurgery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Neurosurgery by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Latin America 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 215: Latin America Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Latin America Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Latin America 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Argentina 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 224: Argentina Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Argentina Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Argentina 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Brazil 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 233: Brazil Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Brazil Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Brazil 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Mexico 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 242: Mexico Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Mexico Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Mexico 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Latin America Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Latin America 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Neurosurgery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Neurosurgery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Neurosurgery by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Middle East 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 263: Middle East Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Middle East Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Middle East 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Iran 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 272: Iran Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Iran Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Iran 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Israel 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 281: Israel Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Israel Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Israel 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Saudi Arabia Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Saudi Arabia 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: UAE 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 299: UAE Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: UAE Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: UAE 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Middle East Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Middle East 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• AFRICA
  • Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Africa 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 317: Africa Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Africa Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Africa 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION